News
Jobs
Career Advice
Companies
Hotbeds
More

SUBSCRIBE

SUBSCRIBE

News
Jobs
Career Advice
Companies
Hotbeds
More

Search Query

Search Results

143,666 Results

Type

Article (7038)
Company Profile (21)
Press Release (136607)

Section

Business (53018)
Career Advice (342)
Deals (9417)
Drug Delivery (4)
Drug Development (19749)
Employer Resources (17)
FDA (3651)
Job Trends (3852)
News (84122)
Policy (6507)

Tag

Date

Today (24)
Last 7 days (113)
Last 30 days (460)
Last 365 days (9937)
2024 (5480)
2023 (10668)
2022 (12589)
2021 (13394)
2020 (12175)
2019 (10318)
2018 (7684)
2017 (10869)
2016 (5959)
2015 (7912)
2014 (5565)
2013 (3712)
2012 (4117)
2011 (4301)
2010 (4210)

Filters

Type

Article (7038)
Company Profile (21)
Press Release (136607)

Section

Business (53018)
Career Advice (342)
Deals (9417)
Drug Delivery (4)
Drug Development (19749)
Employer Resources (17)
FDA (3651)
Job Trends (3852)
News (84122)
Policy (6507)

Tag

Date

Today (24)
Last 7 days (113)
Last 30 days (460)
Last 365 days (9937)
2024 (5480)
2023 (10668)
2022 (12589)
2021 (13394)
2020 (12175)
2019 (10318)
2018 (7684)
2017 (10869)
2016 (5959)
2015 (7912)
2014 (5565)
2013 (3712)
2012 (4117)
2011 (4301)
2010 (4210)

143,666 Results for "17".

Sort By

Augustine Therapeutics Raises EUR 17 Million in a Series A First Closing to Advance Lead Candidate Into Clinical Development in Neurological Diseases

Augustine Therapeutics, a pioneering biotech company focused on novel treatments for neurodegenerative and cardiometabolic diseases, announced that it has raised EUR 17 million in the first closing of its Series A round.

June 26, 2024
·
6 min read
Genetown

Access Reminder for Bruker Investor Webinar on May 17, 2024

Bruker Corporation will host an Investor Webinar from 10 am to about 12 noon Eastern Daylight Time tomorrow May 17, 2024, to provide additional insights into its three recent acquisitions of Chemspeed, ELITech, and of the NanoString business.

May 16, 2024
·
2 min read
Genetown

Bruker Corporation to Host Investor Webinar on May 17, 2024

Bruker Corporation (Nasdaq: BRKR) today announced it intends to hold an Investor Webinar from 10 am to about 12 noon Eastern Daylight Time (EDT) on May 17, 2024, to provide additional insights into its three recent acquisitions of Chemspeed, ELITech, and of the NanoString business.

May 9, 2024
·
1 min read
Genetown

Adaptilens Announces $17.5M Series a Financing

Adaptilens, Inc., a pre-clinical company dedicated to transforming the standard of care for cataract surgery, announced the closing of a Series A financing round of $17.5 million led by Perceptive Xontogeny Venture Funds, with additional investments from Pillar VC, 380 Cap, and Accanto Partners.

April 29, 2024
·
3 min read
Avelos Therapeutics Announces KRW 17 Billion Series B Funding Round, Surpassing KRW 30 Billion Total Raised

Avelos Therapeutics, a leading innovator in the development of novel anti-cancer drugs, recently completed a successful Series B funding round totaling KRW 17 billion on April 30.

May 29, 2024
·
4 min read
Biotech Bay

Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - May 17, 2024

Ultragenyx Pharmaceutical Inc. reported the grant of 17,180 restricted stock units of the company’s common stock to ten newly hired non-executive officers of the company.

May 17, 2024
·
1 min read
Drug Development

Opus Genetics Announces $1.7 Million in Project-based Funding from the Foundation Fighting Blindness to Support Two Preclinical Programs

Opus Genetics, a patient-first, clinical-stage gene therapy company developing treatments for inherited retinal diseases, announced it has received $1.7 million in project-based funding from the Foundation Fighting Blindness to help advance two preclinical candidate programs.

June 13, 2024
·
3 min read
Biotech Bay

Mirum Pharmaceuticals to Host Investor Call to Share Interim Analysis Results from the Volixibat VANTAGE and VISTAS studies on June 17, 2024

Mirum Pharmaceuticals, Inc. announced that it will host an investor call on Monday, June 17 at 8:30 a.m. ET to share interim analysis results from the Volixibat VANTAGE Phase 2b study in primary biliary cholangitis and the Volixibat VISTAS Phase 2b study in primary sclerosing cholangitis.

June 16, 2024
·
2 min read
Drug Development

PolyPid to Host Virtual KOL Event on June 17, 2024, and Provide an Update on the Company’s Ongoing D-PLEX₁₀₀ Phase 3 Trial

PolyPid Ltd. announced that it will host a virtual Key Opinion Leader event on Monday, June 17, 2024, at 10:00 AM ET, to discuss the significant unmet medical need in surgical site infections and provide an update on the Company’s ongoing D-PLEX100 Phase 3 trial.

June 10, 2024
·
5 min read
Synthetic Biology Industry is Rising Rapidly Up to USD 80.17 Bn by 2033

The global synthetic biology market size was worth around USD 14.09 billion in 2024 and is predicted to grow around USD 80.17 billion by 2033 with a compound annual growth rate (CAGR) of roughly 18.99% between 2024 and 2033 According to a new report by Nova One Advisor.

April 22, 2024
·
13 min read

1 of 14,367

BioSpace is the digital hub for life science news and jobs. We provide essential insights, opportunities and tools to connect innovative organizations and talented professionals who advance health and quality of life across the globe.

Explore
Hotbeds
About
More

© 1985 - 2024 BioSpace.com. All rights reserved.

twitter
instagram
facebook
linkedin